A pessimistic view on the future of drugs
1994

The Future of Drug Development

Editorial

Author Information

Author(s): H. Timmerman

Primary Institution: Leiden/Amsterdam Center for Drug Research, Vrije Universiteit

Conclusion

The future of drug development is uncertain due to rising costs and reduced consumption of medicines, despite advancements in scientific knowledge.

Supporting Evidence

  • Drug development costs are increasing while the consumption of medicines is decreasing.
  • Many predictions about drug development have proven to be incorrect.
  • The pharmaceutical industry faces uncertainty due to financial pressures.

Takeaway

Making new medicines is getting harder because it costs a lot of money and people are buying less medicine. Even though we know a lot more about how to make drugs, the future looks a bit gloomy.

Potential Biases

The editorial may reflect a bias towards pessimism regarding the future of drug development.

Limitations

The editorial discusses the uncertainty in drug development and the financial challenges faced by pharmaceutical companies.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication